MentionFox
Home › Stakes › Organigram Global Inc.
5%+ stakes · Schedule 13D and 13G

Organigram Global Inc.: 5%+ holders

Who has reported owning 5% or more of Organigram Global Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more1
Filings2
Latest filing2026-04-17

Organigram Global Inc. has 2 Schedule 13D or 13G filings on record since 2026-02-20. 1 holder's latest filing reports 5% or more of common shares, no par value. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
BT DE Investments Inc.29.9%42,231,089SCHEDULE 13D/A, 2026-04-172026-04-15

Purpose of Transaction (Item 4)

BT DE Investments Inc.

As previously disclosed, on February 18, 2026, the Issuer entered into a Share Sale and Purchase Agreement Regarding Shares in Sanity Group GmbH, dated as of February 18, 2026, among the Issuer, Sanity Group GmbH ("Sanity"), and the other persons party thereto (the "SPA") to indirectly acquire all of the issued and outstanding shares of Sanity not currently owned by the Issuer, including shares of Sanity owned by the Purchaser (the "Acquisition"). The Acquisition was completed on April 15, 2026. Pursuant to the Acquisition, the sellers listed in the SPA received upfront consideration (the "Upfront Consideration"), and subject to the achievement of certain financial performance metrics of Sanity for the twelve months following closing of the Acquisition, will be entitled to receive certain earnout consideration (the "Earnout Consideration"). The Purchaser elected to receive consideration consisting of Shares of the Issuer under the SPA in lieu of cash for its interest in Sanity. As previously disclosed, in order to finance the cash component of the Acquisition and the Issuer's transaction expenses, the Purchaser executed and delivered a subscription agreement, dated February 18, 2026 (the "Subscription Agreement"), with the Issuer to acquire Shares on a private placement basis (the "Private Placement Investment"), increasing the Purchaser's strategic investment in the Issuer. The Private Placement Investment was comprised of an exercise by the Purchaser of certain existing …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-04-17; the filing has the rest

Timeline

FiledHolderPercentFiling
2026-02-20BT DE Investments Inc.29.7%SCHEDULE 13D/A
2026-04-17BT DE Investments Inc.29.9%SCHEDULE 13D/A

Tools for this story

Each opens in a new tab, filled in for Organigram Global Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/organigram-global
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2
Organigram Global Inc. 5%+ holders: 1 at 5% or more, largest BT DE Investments Inc. 29.9%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/organigram-global